Compare $ONCO vs $ORGS | Chartloom

Compare

$ONCO vs $ORGS

Onconetix Inc · Orgenesis Inc

ONCO

Onconetix Inc

ORGS

Orgenesis Inc

Compare $ONCO vs $ORGS

Comparing Onconetix Inc and Orgenesis Inc

ONCOOnconetix Inc

ORGSOrgenesis Inc

ONCOOnconetix Inc

Market cap

$2M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-51.3%

YTD performance

-99.2%

52W performance

-99.7%

FCF yield

-420.9%

ORGSOrgenesis Inc

Market cap

$3M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-92.8%

YTD performance

133.3%

52W performance

-56.3%

FCF yield

-505.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ONCO

ORGS

Detailed metrics comparison

ONCO

Onconetix Inc

ORGS

Orgenesis Inc

Market Cap

ONCO$2M

ORGS$3M

Enterprise Value

ONCO$-3M

ORGS$20M

Price

ONCO$0.62

ORGS$0.35

P/E Ratio

ONCON/A

ORGSN/A

P/S Ratio

ONCO3.79x

ORGS3.31x

EV/Sales

ONCO-5.18x

ORGS19.39x

EV/EBITDA

ONCO0.00x

ORGS0.00x

P/B Ratio

ONCO0.24x

ORGS0.28x

P/FCF Ratio

ONCON/A

ORGSN/A

EV/FCF

ONCO0.32x

ORGS-1.16x

PEG Ratio

ONCON/A

ORGSN/A

Forward P/E (NTM)

ONCON/A

ORGSN/A

Forward P/S (NTM)

ONCON/A

ORGSN/A

Revenue (TTM)

ONCO$646K

ORGS$1M

Revenue Growth (YoY)

ONCO-51.3%

ORGS-92.8%

Forward Rev Growth

ONCO0.0%

ORGS0.0%

Gross Margin (TTM)

ONCO80.4%

ORGS-86.3%

Operating Margin (TTM)

ONCO0.0%

ORGS0.0%

EBITDA Margin (TTM)

ONCO-1188.1%

ORGS-1868.2%

Net Margin (TTM)

ONCO-1578.8%

ORGS-4653.6%

FCF Margin (TTM)

ONCO-1596.2%

ORGS-1675.3%

Net Income (TTM)

ONCO$-10M

ORGS$-48M

FCF (TTM)

ONCO$-10M

ORGS$-17M

EPS (TTM)

ONCO-$4.55

ORGS-$9.58

ROE (TTM)

ONCO-9194.0%

ORGS-10936.0%

ROA (TTM)

ONCO-5376.0%

ORGS-20820.0%

ROIC (TTM)

ONCO-9080.0%

ORGS-5864.0%

Cash

ONCO$6M

ORGS$78K

Debt

ONCO$150K

ORGS$17M

Net Cash/Debt

ONCO$6M

ORGS$-17M

Current Ratio (TTM)

ONCO2.21x

ORGS0.03x

Quick Ratio (TTM)

ONCO2.04x

ORGS0.03x

Debt/Equity (TTM)

ONCO0.01x

ORGS1.73x

Debt/Assets (TTM)

ONCO0.0%

ORGS0.0%

Interest Coverage (TTM)

ONCON/A

ORGSN/A

Net Debt/EBITDA (TTM)

ONCO0.00x

ORGS0.00x

Beta

ONCO2.60

ORGS3.73

52W Performance

ONCO-99.7%

ORGS-56.3%

YTD Performance

ONCO-99.2%

ORGS133.3%

% from 52W High

ONCO-99.7%

ORGS-65.0%

% from 52W Low

ONCO6.9%

ORGS34900.0%

Asset Turnover (TTM)

ONCO0.03x

ORGS0.04x

FCF Yield (TTM)

ONCO-420.9%

ORGS-505.5%

Earnings Yield (TTM)

ONCO-416.3%

ORGS-1404.2%

Dividend Yield (TTM)

ONCON/A

ORGSN/A

Rule of 40

ONCO-1,647.5

ORGS-1,768.0

EV/GP/RG

ONCON/A

ORGSN/A

Ticker research

View ONCO research View ORGS research

Metric	ONCO Onconetix Inc	ORGS Orgenesis Inc
Market & Valuation
Market Cap	$2M	$3M
Enterprise Value	$-3M	$20M
Price	$0.62	$0.35
P/E Ratio	N/A	N/A
P/S Ratio	3.79x	3.31x
EV/Sales	-5.18x	19.39x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.24x	0.28x
P/FCF Ratio	N/A	N/A
EV/FCF	0.32x	-1.16x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$646K	$1M
Revenue Growth (YoY)	-51.3%	-92.8%
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	80.4%	-86.3%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1188.1%	-1868.2%
Net Margin (TTM)	-1578.8%	-4653.6%
FCF Margin (TTM)	-1596.2%	-1675.3%
Net Income (TTM)	$-10M	$-48M
FCF (TTM)	$-10M	$-17M
EPS (TTM)	-$4.55	-$9.58
ROE (TTM)	-9194.0%	-10936.0%
ROA (TTM)	-5376.0%	-20820.0%
ROIC (TTM)	-9080.0%	-5864.0%
Financial Health
Cash	$6M	$78K
Debt	$150K	$17M
Net Cash/Debt	$6M	$-17M
Current Ratio (TTM)	2.21x	0.03x
Quick Ratio (TTM)	2.04x	0.03x
Debt/Equity (TTM)	0.01x	1.73x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.60	3.73
52W Performance	-99.7%	-56.3%
YTD Performance	-99.2%	133.3%
% from 52W High	-99.7%	-65.0%
% from 52W Low	6.9%	34900.0%
Efficiency & Yields
Asset Turnover (TTM)	0.03x	0.04x
FCF Yield (TTM)	-420.9%	-505.5%
Earnings Yield (TTM)	-416.3%	-1404.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-1,647.5	-1,768.0
EV/GP/RG	N/A	N/A
Ticker research	View ONCO research	View ORGS research

Valuation

P/S Ratio

ORGS

3.31x

ONCO

3.79x

EV/FCF

ORGS

-1.16x

ONCO

0.32x

Growth & revenue

Revenue Growth TTM

ONCO

-51.3%

ORGS

-92.8%

Forward Revenue Growth

ONCO

0.0%

ORGS

0.0%

Profitability & performance

Gross Margin

ONCO

80.4%

ORGS

-86.3%

ROE

ONCO

-9194.0%

ORGS

-10936.0%

FCF Yield %

ONCO

-420.9%

ORGS

-505.5%

52-Week Performance

ORGS

-56.3%

ONCO

-99.7%

Detailed metrics comparison

ONCO

Onconetix Inc

ORGS

Orgenesis Inc

Market Cap

ONCO$2M

ORGS$3M

Enterprise Value

ONCO$-3M

ORGS$20M

Price

ONCO$0.62

ORGS$0.35

P/E Ratio

ONCON/A

ORGSN/A

P/S Ratio

ONCO3.79x

ORGS3.31x

EV/Sales

ONCO-5.18x

ORGS19.39x

EV/EBITDA

ONCO0.00x

ORGS0.00x

P/B Ratio

ONCO0.24x

ORGS0.28x

P/FCF Ratio

ONCON/A

ORGSN/A

EV/FCF

ONCO0.32x

ORGS-1.16x

PEG Ratio

ONCON/A

ORGSN/A

Forward P/E (NTM)

ONCON/A

ORGSN/A

Forward P/S (NTM)

ONCON/A

ORGSN/A

Revenue (TTM)

ONCO$646K

ORGS$1M

Revenue Growth (YoY)

ONCO-51.3%

ORGS-92.8%

Forward Rev Growth

ONCO0.0%

ORGS0.0%

Gross Margin (TTM)

ONCO80.4%

ORGS-86.3%

Operating Margin (TTM)

ONCO0.0%

ORGS0.0%

EBITDA Margin (TTM)

ONCO-1188.1%

ORGS-1868.2%

Net Margin (TTM)

ONCO-1578.8%

ORGS-4653.6%

FCF Margin (TTM)

ONCO-1596.2%

ORGS-1675.3%

Net Income (TTM)

ONCO$-10M

ORGS$-48M

FCF (TTM)

ONCO$-10M

ORGS$-17M

EPS (TTM)

ONCO-$4.55

ORGS-$9.58

ROE (TTM)

ONCO-9194.0%

ORGS-10936.0%

ROA (TTM)

ONCO-5376.0%

ORGS-20820.0%

ROIC (TTM)

ONCO-9080.0%

ORGS-5864.0%

Cash

ONCO$6M

ORGS$78K

Debt

ONCO$150K

ORGS$17M

Net Cash/Debt

ONCO$6M

ORGS$-17M

Current Ratio (TTM)

ONCO2.21x

ORGS0.03x

Quick Ratio (TTM)

ONCO2.04x

ORGS0.03x

Debt/Equity (TTM)

ONCO0.01x

ORGS1.73x

Debt/Assets (TTM)

ONCO0.0%

ORGS0.0%

Interest Coverage (TTM)

ONCON/A

ORGSN/A

Net Debt/EBITDA (TTM)

ONCO0.00x

ORGS0.00x

Beta

ONCO2.60

ORGS3.73

52W Performance

ONCO-99.7%

ORGS-56.3%

YTD Performance

ONCO-99.2%

ORGS133.3%

% from 52W High

ONCO-99.7%

ORGS-65.0%

% from 52W Low

ONCO6.9%

ORGS34900.0%

Asset Turnover (TTM)

ONCO0.03x

ORGS0.04x

FCF Yield (TTM)

ONCO-420.9%

ORGS-505.5%

Earnings Yield (TTM)

ONCO-416.3%

ORGS-1404.2%

Dividend Yield (TTM)

ONCON/A

ORGSN/A

Rule of 40

ONCO-1,647.5

ORGS-1,768.0

EV/GP/RG

ONCON/A

ORGSN/A

Ticker research

View ONCO research View ORGS research

Metric	ONCO Onconetix Inc	ORGS Orgenesis Inc
Market & Valuation
Market Cap	$2M	$3M
Enterprise Value	$-3M	$20M
Price	$0.62	$0.35
P/E Ratio	N/A	N/A
P/S Ratio	3.79x	3.31x
EV/Sales	-5.18x	19.39x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.24x	0.28x
P/FCF Ratio	N/A	N/A
EV/FCF	0.32x	-1.16x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$646K	$1M
Revenue Growth (YoY)	-51.3%	-92.8%
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	80.4%	-86.3%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1188.1%	-1868.2%
Net Margin (TTM)	-1578.8%	-4653.6%
FCF Margin (TTM)	-1596.2%	-1675.3%
Net Income (TTM)	$-10M	$-48M
FCF (TTM)	$-10M	$-17M
EPS (TTM)	-$4.55	-$9.58
ROE (TTM)	-9194.0%	-10936.0%
ROA (TTM)	-5376.0%	-20820.0%
ROIC (TTM)	-9080.0%	-5864.0%
Financial Health
Cash	$6M	$78K
Debt	$150K	$17M
Net Cash/Debt	$6M	$-17M
Current Ratio (TTM)	2.21x	0.03x
Quick Ratio (TTM)	2.04x	0.03x
Debt/Equity (TTM)	0.01x	1.73x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.60	3.73
52W Performance	-99.7%	-56.3%
YTD Performance	-99.2%	133.3%
% from 52W High	-99.7%	-65.0%
% from 52W Low	6.9%	34900.0%
Efficiency & Yields
Asset Turnover (TTM)	0.03x	0.04x
FCF Yield (TTM)	-420.9%	-505.5%
Earnings Yield (TTM)	-416.3%	-1404.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-1,647.5	-1,768.0
EV/GP/RG	N/A	N/A
Ticker research	View ONCO research	View ORGS research